AAAAAA

   
Results: 1-19 |
Results: 19
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group
Authors: Jourdan, E Reiffers, J Stoppa, AM Sotto, JJ Attal, M Bouabdallaha, R Marit, G Fegueux, N Boulat, O Dastugue, N Boiron, JM Faberes, C Gastaut, JA Maraninchi, D Blaise, D
Citation: E. Jourdan et al., Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group, LEUK LYMPH, 42(1-2), 2001, pp. 57-65
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials
Authors: Bouabdallah, R Stoppa, AM Coso, D Bardou, VJ Blaise, D Chabannon, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy
Authors: Brenot-Rossi, I Bouabdallah, R Di Stefano, D Bardou, VJ Stoppa, AM Camerlo, J Sauvan, R Gastaut, JA Pasquier, J
Citation: I. Brenot-rossi et al., Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy, EUR J NUCL, 28(10), 2001, pp. 1482-1488
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370
Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission
Authors: Blaise, D Attal, M Reiffers, J Michallet, M Bellanger, C Pico, JL Stoppa, AM Payen, C Marit, G Bouabdallah, R Sotto, JJ Rossi, JF Brandely, M Hercend, T Maraninchi, D
Citation: D. Blaise et al., Randomized study of recombinant interleukin-2 after autologous bone marrowtransplantation for acute leukemia in first complete remission, EUR CYTOKIN, 11(1), 2000, pp. 91-97
Anti-CD20 monoclonal antibody therapy in Epstein-Barr virus-associated B cell lymphoma following lung transplantation
Authors: Reynaud-Gaubert, M Stoppa, AM Gaubert, JY Thomas, P Fuentes, P
Citation: M. Reynaud-gaubert et al., Anti-CD20 monoclonal antibody therapy in Epstein-Barr virus-associated B cell lymphoma following lung transplantation, J HEART LUN, 19(5), 2000, pp. 492-495
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
Authors: Milpied, N Vasseur, B Parquet, N Garnier, JL Antoine, C Quartier, P Carret, AS Bouscary, D Faye, A Bourbigot, B Reguerre, Y Stoppa, AM Bourquard, P de Ligny, BH Dubief, F Mathieu-Boue, A Leblond, V
Citation: N. Milpied et al., Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients, ANN ONCOL, 11, 2000, pp. 113-116
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
Authors: Fenaux, P Chevret, S Guerci, A Fegueux, N Dombret, H Thomas, X Sanz, M Link, H Maloisel, F Gardin, C Bordessoule, D Stoppa, AM Sadoun, A Muus, P Wandt, H Mineur, P Whittaker, JA Fey, M Daniel, MT Castaigne, S Degos, L
Citation: P. Fenaux et al., Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1371-1377
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
Authors: Mohty, M Faucher, C Vey, N Stoppa, AM Viret, F Chabbert, I Chabannon, C Bouabdallah, R Ladaique, P Collet, L Zandotti, C Maraninchi, D Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255
Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers
Authors: Gravis, G Viens, P Vey, N Blaise, D Stoppa, AM Olive, D Maraninchi, D
Citation: G. Gravis et al., Pilot study of immunotherapy with interleukin-2 after autologous stem celltransplantation in advanced breast cancers, ANTICANC R, 20(5C), 2000, pp. 3987-3991
Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients
Authors: Vey, N Blaise, D Lafage, M Olive, D Viens, P Baume, D Camerlo, J Stoppa, AM Gabus, R Brandely, M Hercend, T Maraninchi, D
Citation: N. Vey et al., Treatment of chronic myelogenous leukemia with interleukin-2: A phase II study in 21 patients, J IMMUNOTH, 22(2), 1999, pp. 175-181
T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells
Authors: Olivero, S Novakovitch, G Ladaique, P Sainty, D Viret, F Faucher, C Stoppa, AM Blaise, D Chabannon, C
Citation: S. Olivero et al., T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells, CYTOTHERAPY, 1(6), 1999, pp. 469-477
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement
Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
Authors: Thomas, X Fenaux, P Dombret, H Delair, S Dreyfus, F Tilly, H Vekhoff, A Cony-Makhoul, P Leblond, V Troussard, X Cordonnier, C de Revel, T Simon, M Nicolini, F Stoppa, AM Janvier, M Bordessoule, D Rousselot, P Ffrench, M Marie, JP Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation
Authors: Gahrton, G Svensson, H Bjorkstrand, B Apperley, J Carlson, K Cavo, M Ferrant, A Fouillard, L Gratecos, N Gratwohl, A Guilhot, F Deliliers, GL Ljungman, P Masszi, T Milligan, DW Powles, RL Reiffers, J Samson, JD Stoppa, AM Vernant, JP Volin, L Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD
Authors: Viret, F Chabannon, C Aurran-Schleinitz, T Reviron, D Stoppa, AM Faucher, C Ladaique, P Gastaut, JA Maraninchi, D Blaise, D
Citation: F. Viret et al., Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD, BONE MAR TR, 24(2), 1999, pp. 225-227
FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis
Authors: Xerri, L Devilard, E Bouabdallah, R Stoppa, AM Hassoun, J Birg, F
Citation: L. Xerri et al., FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis, BR J HAEM, 106(3), 1999, pp. 652-661
A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia
Authors: Maraninchi, D Vey, N Viens, P Stoppa, AM Archimbaud, E Attal, M Baume, D Bouabdallah, R Demeoq, F Fleury, J Michallet, M Olive, D Reiffers, J Sainty, D Tabilio, A Tiberghien, P Brandely, M Hercend, T Blaise, D
Citation: D. Maraninchi et al., A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 343-349
Risultati: 1-19 |